slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 6,601-6,630
Pages 350
Rows per page 30
Slide type
6,601-6,630 of 10,471
13
Uses a Land & Expand framework to present customer count and net revenue retention.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
14
Includes CAGR metrics and margin percentages for EBITDA.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
06
The slide details a specific corporate partnership deal structure.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
20
Includes clinical trial data and visual evidence of skin improvement.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
21
Equillium | Investor Presentation Deck | 40 slidesEquillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
23
Includes visual longitudinal study (Day 0, 14, 21) and a bar chart comparing PBS, Ruxolitinib, and EQ101.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
04
The chart demonstrates organizational scaling in compliance-related functions.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
06
The chart uses a trend line to emphasize the downward trajectory of concentration.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
13
The slide uses a stacked bar chart to show the composition of expenses and a table to show operational metrics.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
15
The slide uses four bar charts to visualize financial performance metrics.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
16
The slide presents a mix of absolute dollar figures and percentage-based profitability ratios.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
17
The slide shows a decline in net interest margin despite stable net interest income, and a breakdown of non-interest income components.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
21
The slide highlights financial performance metrics.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
04
The slide uses a three-column layout to summarize key value propositions supported by clinical trial data.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
10
The slide outlines the trial parameters (n=27) and highlights the transition to the OnPrime Phase 3 trial.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
11
Data presented in a table format comparing patient cohorts against clinical metrics.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
12
Waterfall plot and spider plot showing patient-level clinical outcomes.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
13
The slide uses a before-after comparison for three specific patients (15B-01, 15B-15, 15B-17) to demonstrate clinical efficacy.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
14
Includes a comparison table of historical data vs ELAHARE and a specific VIRO-15 clinical outcome table.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
17
Includes Kaplan-Meier survival curves and patient cohort descriptions for two separate study groups.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
18
Includes specific patient case reports with RECIST criteria and biomarker data.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
19
Includes a bio for Benny Li, CEO of Newsoara.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
20
Genelux | Investor Presentation Deck | 37 slidesGenelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
32
The slide uses two distinct chart types (spaghetti plot and waterfall plot) to validate the efficacy of the treatment.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
33
Includes a patient profile, a bar chart comparing PFS across treatment lines, and a longitudinal line chart tracking tumor size and CA-125 levels.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
34
Includes patient-specific histological evidence (Pt.#15A-01 and Pt.#15A-11) demonstrating the mechanism of action.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
35
The slide uses histology images and HALO infiltration histograms to demonstrate the mechanism of action and clinical efficacy.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
36
The slide uses a combination of clinical timeline, patient history, and immunological data (ELISPOT) to correlate T-cell response with clinical outcome.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
06
The slide acts as a visual summary of recent business momentum.Gogoro | Investor Presentation Deck | 29 slides · Gogoro
Pitch deck Investor relations 1 hit
08
PGBN stands for Powered by Gogoro Network.Gogoro | Investor Presentation Deck | 29 slides · Gogoro
Pitch deck Investor relations Beat · Problem1 hit